NAGE Q4 2017 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+33.5% YoY

Gross Profit

$4M50.9% margin

Operating Income

-$9M-116.6% margin

Net Income

-$9M-117.1% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+23.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$63M

Total Liabilities

$9M

Stockholders' Equity

$54M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+33.5%
Gross Profit	$4M	$2M	+66.8%
Operating Income	-$9M	-$2M	-313.3%
Net Income	-$9M	-$2M	-310.9%